Background: The study explores mechanisms of intradialytic hemodynamic instability, which remains a significant challenge in the management of chronic kidney disease patients undergoing hemodialysis. Understanding the factors contributing to this condition is crucial for enhancing patient outcomes. Objective: To review and analyze the primary pathophysiological mechanisms leading to intradialytic hemodynamic instability. Material and Methods: The review synthesizes data from recent studies and clinical trials focused on hemodynamic changes during hemodialysis. The analysis includes factors like plasma volume reduction, myocardial contractility, and systemic perfusion. Results: The main mechanisms of intradialytic hemodynamic instability involve decreased plasma volume, reduced venous return, lower left ventricular preload and contractility, and diminished stroke and minute volumes. Secondary contributing factors include chronotropic insufficiency, pathological myocardial remodeling, and systemic and regional perfusion deficits affecting abdominal, cerebral, and coronary circulation. Conclusion: Comprehensive understanding of the pathogenesis of intradialytic hemodynamic instability highlights the importance of targeted therapeutic interventions to mitigate cardiovascular risks and improve patient quality of life.
| Mualliflar | Муминов , Ш, Косимова, Г, Muminov , Shovkat, Kosimova , Gozal, Muminov , Shovkat, Kosimova , Gozal |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-06-30 |
| Jild | 1 |
| Son | 2 |
| Betlar | 143-147 |
| Til | Rus |
| DOI | 10.70626/cardiouz-2024-1-00017 |
DOI: 10.70626/cardiouz-2024-1-00017 · Maqolaning asl sahifasi
chronic kidney disease, hemodialysis, intradialytic hypotension, central hemodynamics, cardiovascular risks, myocardial dysfunction, xроническая болезнь почек, гемодиализ, интрадиализная гипотензия, центральная гемодинамика, кардиоваскулярные риски, миокардиальная дисфункция, surunkali buyrak kasalligi, gemodializ, intradialitik gipotenziya, Markaziy gemodinamika, yurak-qon tomir xavflari, miokard disfunktsiyasi
Background. Arterial hypertension (AH) is a complex, multifactorial disease that significantly contributes to cardiovascular diseases. It is particularly prevalent in the Aral Sea region, where both genetic and…
Background. The purpose of this study was to compare the tolerability, safety, and clinical efficacy of generic and original apixaban in patients with arterial hypertension (AH) and permanent non-valvular atrial…
Background. Chronic heart failure (CHF) often requires ongoing management, and patients with CHF face significant challenges related to self-care and self-management. This study aimed to assess the effectiveness of a…
Background. Dissecting aortic aneurysm (DAA) remains a critical issue in modern medicine, characterized by complex clinical presentations that mimic various pathologies. The diagnosis is often challenging due to the…
Background. To investigate the association between metabolically associated steatotic liver disease (MASLD) and ischemic heart disease (IHD), focusing on the clinical aspects of their comorbidity. Materials and methods…
Background. To study the possibility of using epicardial fat thickness (EFT) as an additional non-invasive diagnostic criteria and risk stratification in patients with coronary artery disease and cardiometabolic…
Background. Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening condition associated with heart failure after childbirth. Genetic factors, including the angiotensin-converting enzyme (ACE) gene…
Background. Uncontrolled arterial hypertension in patients at high and very high cardiovascular risk remains a significant issue in modern medicine. Optimizing antihypertensive therapy using fixed or separate…
Background. Heart failure with preserved ejection fraction (HFpEF) is a complex clinical condition, often associated with chronic kidney disease (CKD). The interplay between these two conditions remains underexplored…
Background.Reperfusion therapies, including primary percutaneous coronary intervention (PCI), thrombolysis, and salvage PCI, are crucial for treating patients with ST-segment elevation myocardial infarction (STEMI)…